Renaissance Technologies
ITRM

Renaissance Technologies’s Iterum Therapeutics ITRM Stock Holding History

Renaissance Technologies’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-81,694
Closed -$54.7K – 3495
2025
Q3 		$54.7K Sell
81,694
-390,206
-83% -$306K ﹤0.01% 3327
2025
Q2 		$470K Buy
471,900
+231,000
+96% +$241K ﹤0.01% 2865
2025
Q1 		$296K Sell
240,900
-197,916
-45% -$294K ﹤0.01% 2929
2024
Q4 		$777K Buy
+438,816
New +$688K ﹤0.01% 2623
2024
Q3 		– Sell
-64,022
Closed -$73.3K – 3705
2024
Q2 		$73.3K Sell
64,022
-46,304
-42% -$67.1K ﹤0.01% 3237
2024
Q1 		$170K Buy
110,326
+60,404
+121% +$98.2K ﹤0.01% 3267
2023
Q4 		$98K Buy
49,922
+3,000
+6% +$3.72K ﹤0.01% 3305
2023
Q3 		$38K Buy
46,922
+4,138
+10% +$3.93K ﹤0.01% 3440
2023
Q2 		$46K Buy
42,784
+3,900
+10% +$4.32K ﹤0.01% 3632
2023
Q1 		$39K Buy
38,884
+1,800
+5% +$2.08K ﹤0.01% 3710
2022
Q4 		$31K Buy
37,084
+2,400
+7% +$3.41K ﹤0.01% 3883
2022
Q3 		$56K Buy
34,684
+13,131
+61% +$39.8K ﹤0.01% 3724
2022
Q2 		$65K Buy
21,553
+14,346
+199% +$53.7K ﹤0.01% 3949
2022
Q1 		$38K Sell
7,207
-1,273
-15% -$7.36K ﹤0.01% 3943
2021
Q4 		$50K Sell
8,480
-34,491
-80% -$266K ﹤0.01% 3783
2021
Q3 		$360K Sell
42,971
-176,316
-80% -$2.17M ﹤0.01% 3017
2021
Q2 		$7.6M Buy
+219,287
New +$4.75M 0.01% 1368
2021
Q1 		– Sell
-48,860
Closed -$725K – 3504
2020
Q4 		$725K Buy
+48,860
New +$572K ﹤0.01% 2658

Other funds holding ITRM

AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $213M AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Renaissance Technologies's ITRM Position: Q4 2025 in Review

Renaissance Technologies sold out of Iterum Therapeutics (ITRM) in Q4 2025, closing a stake of 81,694 shares — an estimated $54.7K sold.

Renaissance Technologies first reported a position in ITRM in Q4 2020 and held it in 18 quarters. The position peaked at $7.6M in Q2 2021. 20 funds tracked by Wall St. Rank hold ITRM as of Q4 2025.

  • Renaissance Technologies reported no remaining Iterum Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 81,694 Iterum Therapeutics shares in Q4 2025, an estimated $54.7K.
  • Renaissance Technologies first reported a position in Iterum Therapeutics in Q4 2020 and held it in 18 quarters.
  • Renaissance Technologies's Iterum Therapeutics position peaked at $7.6M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.